CovalX Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
CovalX General Information
Description
Operator of a biotechnology company intended to provide technology and services in the field of protein interaction analysis based on mass spectrometry. The company develops innovative analysis alternatives for the characterization of therapeutic proteins and protein interactions for the life science industry, enabling pharmaceutical companies, life science industries, and academic laboratories to achieve high-quality results for the analysis of protein complexes, antibodies, and therapeutic proteins.
Contact Information
Website
www.covalx.comCorporate Office
- Schützengasse 23
- 8001 Zurich
- Switzerland
Corporate Office
- Schützengasse 23
- 8001 Zurich
- Switzerland
CovalX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Grant | 23-Aug-2011 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 09-Jun-2008 | $1.66M | $1.66M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2005 | Completed | Startup |
CovalX Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
CovalX Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CovalX Patents
CovalX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20110177617-A1 | Cross-linking reagents for molecular interactions analysis | Inactive | 29-May-2009 | ||
| JP-2012528119-A | Cross-linking reagent for intermolecular interaction analysis | Pending | 29-May-2009 | ||
| EP-2435464-B1 | Cross-linking reagents for molecular interaction analysis | Active | 29-May-2009 | ||
| EP-2435464-A1 | Cross-linking reagents for molecular interactions analysis | Active | 29-May-2009 | ||
| US-8487242-B2 | Detector device for high mass ion detection, a method for analyzing ions of high mass and a device for selection between ion detectors | Active | 04-Jan-2008 | H01J49/025 |
CovalX Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CovalX Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| StartAngels Network | Angel Group | Minority | ||
| ETH Zurich | University |
CovalX FAQs
-
When was CovalX founded?
CovalX was founded in 2005.
-
Where is CovalX headquartered?
CovalX is headquartered in Zurich, Switzerland.
-
What is the size of CovalX?
CovalX has 22 total employees.
-
What industry is CovalX in?
CovalX’s primary industry is Biotechnology.
-
Is CovalX a private or public company?
CovalX is a Private company.
-
What is CovalX’s current revenue?
The current revenue for CovalX is .
-
How much funding has CovalX raised over time?
CovalX has raised $1.66M.
-
Who are CovalX’s investors?
StartAngels Network and ETH Zurich have invested in CovalX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
